- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting Wnt/beta‐catenin in
CTNNB1
‐mutated endometrial cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 60, Issue 8, Pages 511-523
Publisher
Wiley
Online
2021-05-27
DOI
10.1002/mc.23308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt Signaling in Gynecologic Malignancies
- (2020) Alexandra McMellen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers
- (2019) Marisa R. Moroney et al. GYNECOLOGIC ONCOLOGY
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells
- (2019) Amin A. Ramzan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment
- (2019) V. Deshmukh et al. OSTEOARTHRITIS AND CARTILAGE
- The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
- (2019) Betty Y. Tam et al. CANCER LETTERS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Wnt signalling: conquering complexity
- (2018) Katrin E. Wiese et al. DEVELOPMENT
- A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee
- (2018) V. Deshmukh et al. OSTEOARTHRITIS AND CARTILAGE
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
- (2018) et al. JAMA Oncology
- An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
- (2018) Amy Coopes et al. ENDOCRINE-RELATED CANCER
- Cancer of the corpus uteri
- (2018) Frédéric Amant et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
- (2018) Lindsay J. Wheeler et al. Oncogenesis
- CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
- (2017) Katherine C Kurnit et al. MODERN PATHOLOGY
- Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
- (2016) Lobna Ouldamer et al. BRITISH JOURNAL OF CANCER
- Endometrial cancer: Not your grandmother's cancer
- (2016) Jessica N. McAlpine et al. CANCER
- Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
- (2016) Aline Talhouk et al. GYNECOLOGIC ONCOLOGY
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. NATURE MEDICINE
- β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers
- (2014) Andrea Myers et al. GYNECOLOGIC ONCOLOGY
- Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
- (2014) Yuexin Liu et al. JNCI-Journal of the National Cancer Institute
- Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression
- (2013) Marten van der Zee et al. JOURNAL OF PATHOLOGY
- Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
- (2013) Melissa K McConechy et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer
- (2012) K. D. Proffitt et al. CANCER RESEARCH
- Contemporary management of endometrial cancer
- (2012) Jason D Wright et al. LANCET
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progesterone Inhibition of Wnt/ -Catenin Signaling in Normal Endometrium and Endometrial Cancer
- (2009) Y. Wang et al. CLINICAL CANCER RESEARCH
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Intracellular MUC1 Peptides Inhibit Cancer Progression
- (2008) B. G. Bitler et al. CLINICAL CANCER RESEARCH
- β-catenin mediates glandular formation and dysregulation of β-catenin induces hyperplasia formation in the murine uterus
- (2008) J-W Jeong et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now